These data are in a full agreement with the observation that autoantibody-negative first-degree relatives exhibit proinflammatory Selleckchem Pirfenidone islet-specific T cell responses [14]. As T1D is a cell-mediated disease, the production of autoantibodies is considered to be an accompanying epiphenomenon. Unexpectedly, B lymphoid tyrosine kinase (BLK) was the top-scored immunorelevant gene when the DRLN group was compared to the control samples. Moreover, significant upregulation of genes related to humoral immune responses

such as CD19 and CD22 was also observed. Interestingly, BLK is also expressed in the pancreatic beta cells where it modulates their function [15]. Furthermore, an immunointervention approach based on B lymphocyte depletion resulted in deceleration of the severity associated with the progression of diabetes [16, 17]. However, the specific molecular mechanism(s) underpinning these observations is yet to be elucidated. Among other genes differentially expressed in the DRL group are members of Toll-like receptor family Panobinostat mw (TLRs) involved in non-specific immune responses. Notably, TLR6, TLR2 and their adaptor protein TIRAP (Toll-interleukin 1 receptor domain–containing protein) signalling the presence of evolutionary conserved bacterial structures. In this context, the upregulated status of TLR6, TLR2 and TIRAP is an unexpected finding because viruses rather than bacteria

are considered to be relevant to T1D development [18]. On the other hand, Dasu and Jialal [19] have reported that the amount of TLR2 and TLR4 ligands is significantly elevated in T1D, underscoring the proinflammatory nature of environment in which T1D develops [20]. Castiblanco et al. [21] described TIRAP S180L polymorphism as a common protective factor acting against the development of systemic lupus erythematosus; however, no association

with T1D has been reported so far. In this context, Reynolds and colleagues [22] recently reported that TLR2 signalling in CD4+ T cells promotes Th17 responses and regulates the pathogenesis of autoimmune disease. Thus, TLR signalling could be an important molecular link between innate and adaptive immune mechanisms involved in the pathogenesis of diabetes. As the hallmark of TLR activation is the production of proinflammatory cytokines Nintedanib (BIBF 1120) [23], the upregulated levels of these receptors could rather reflect their ‘default’ expression setting which significantly contributes to inappropriate inflammatory immunopathologies increasing the risk for the development of T1D. The importance of TLR genes in the pathogenesis of T1D is further strengthened by the fact that entire TLR-related signalling network is found to be differentially regulated. From other types of non-specific immune mechanisms, it is necessary to pinpoint the differences related to complement activity.